16 October 2017 - Takis launches a GMP-like DNA Manufacturing Service

Launching Pre-Clinical Plasmid Manufacturing

Professional Quality Plasmids for Pre-Clinical Applications

Takis delivers high purity, low endotoxin plasmid preparations suitable for pre-clinical DNA vaccine and gene therapy research in small (mice, rats, rabbits) and large animals—monkeys, dogs, pigs, etc.

Production of pre-clinical plasmid manufacturing technology has been optimized thanks to our GMP-grade sytems and can be adapted to customer needs to be easily scaled to meet clinical demand without compromising quality.



For more information. contact us.

Follow Us on Linkedin

Takis is a biotech dedicated to cancer research. Our primary objective is the development of innovative therapies based on the principle that our immune system can be “instructed” to recognize the tumor and reject it as a foreign entity.